Skip to content
You are now leaving https://www.ionispharma.com to visit

Zhao, H.T., John, N., Delic, V., Ikeda-Lee, K., Kim, A., Weihofen, A., Swayze, E.E., Kordasiewicz, H.B., West, A.B., and Volpicelli-Daley, L.A.

(2017). LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model. Molecular Therapy – Nucleic Acids 8, 508-519